The Journal of Contemporary Dental Practice

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 16 , ISSUE 12 ( December, 2015 ) > List of Articles


Assessment of DNA Damage in Leukoplakia Patients with Different Degrees of Dysplasia

Mohamed I Hashem, Zeeshan H Ahmad, Mohammed A Binmgren, Sukumaran Anil, Sahar Bin Huraib

Citation Information : Hashem MI, Ahmad ZH, Binmgren MA, Anil S, Huraib SB. Assessment of DNA Damage in Leukoplakia Patients with Different Degrees of Dysplasia. J Contemp Dent Pract 2015; 16 (12):971-976.

DOI: 10.5005/jp-journals-10024-1790

Published Online: 01-05-2016

Copyright Statement:  Copyright © 2015; The Author(s).



Single cell gel electrophoresis (SCGE) assay also known as comet assay is a rapid and highly sensitive fluorescent molecular technique for detecting various forms of deoxyribonucleic acid (DNA) damage at individual cellular level.

Materials and methods

The present study was done to detect the extent of DNA damage in oral leukoplakia (OL) and compare with normal individuals. The sample population was obtained from an outpatient clinic of a tertiary teaching dental institute. A total of 36 consecutive patients with leukoplakia and 10 healthy normal volunteers were recruited for the study and assessed for the extent of DNA damage using SCGE following clinical diagnosis and histological grading. Peripheral blood was obtained by venipuncture and SCGE assay was performed. Mean comet tail length was recorded and analyzed statistically to compare the extent of damage in each group.


The mean comet tail length seen in leukoplakia patients with moderate to severe dysplasia was 1.25 ± 0.14 mm while for the control subjects, it was 0.31 ± 0.10 mm. The difference was statistically significant (p = 0.000). On comparing within the grades of leukoplakia, a progressive trend of increasing tail length was observed with increasing grades of dysplasia.


Deoxyribonucleic acid damage as measured by SCGE is seen in leukoplakia. A stepwise increase in DNA damage levels from healthy controls, through patients with non-dysplastic epithelium to varying grades of dysplasia has been observed indicating the extent of DNA damage in this high risk group.

How to cite this article

Vellappally S, Binmgren MA, Huraib SB, Hashem MI, Patil S, Anil S. Assessment of DNA Damage in Leukoplakia Patients with Different Degrees of Dysplasia. J Contemp Dent Pract 2015;16(12):971-976.

PDF Share
  1. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 1984;53(3):563-568.
  2. Influence of cigarette, pipe, and cigar smoking, removable partial dentures, and age on oral leukoplakia. Oral Surg Oral Med Oral Pathol 1982;54(4):424-429.
  3. Oral health risks of tobacco use and effects of cessation. Int Dent J 2010;60(1):7-30.
  4. Prospective study of alcohol consumption and risk of oral premalignant lesions in men. Cancer Epidemiol Biomarkers Prev 2006;15(4):774-781.
  5. Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis 2011; 17 Suppl 1:58-72.
  6. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;79(3): 321-329.
  7. Clinical risk factors of oral leukoplakia in a representative sample of the US population. Oral Oncol 2004;40(2):158-163.
  8. Oral Oncol 2012;48(7):636-640.
  9. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dent Oral Epidemiol 1980;8(6):283-333.
  10. Studies in oral leukoplakia: a preliminary report on the period pervalence of malignant transformation in leukoplakia based on a follow-up study of 248 patients. J Am Dent Assoc 1968;76(4):767-771.
  11. Evaluation of DNA damage in oral precancerous and squamous cell carcinoma patients by single cell gel electrophoresis. Indian J Dent Res 2011;22(5):735-736.
  12. Loss of heterozygosity: a potential tool in management of oral premalignant lesions? J Oral Pathol Med 2001;30(9):513-520.
  13. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;80(2):188-191.
  14. Subjectivity in evaluating oral epithelial dysplasia, carcinoma in situ and initial carcinoma. J Oral Pathol 1985;14(9):698-708.
  15. Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncol 2010;46(6):423-425.
  16. Prognostic cytokine markers in peripheral blood for oral cavity squamous cell carcinoma identified by multiplexed immunobead-based profiling. Clin Chim Acta 2011;412(11-12):980-987.
  17. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment†. J Proteome Res 2009;8(5):2173-2185.
  18. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978;46(4):518-539.
  19. Single cell gel electrophoresis on peripheral blood leukocytes of patients with oral squamous cell carcinoma. J Oral Pathol Med 1997;26(8):377-380.
  20. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;175(1):184-191.
  21. Significant oral cancer risk associated with low socioeconomic status. Evid Based Dent 2009;10(1):4-5.
  22. The single cell gel (comet) assay as a promising tool for the detection of dna damage induced by compounds used in dental practice: the oral cancer risk assessment. Crit Rev Oncog 2008;14(2):165.
  23. Oral cancer: raising the level of awareness. Dent Update 1995;22(7):269-270.
  24. Advanced methods in the evaluation of premalignant lesions and carcinomas of the oral mucosa. J Oral Pathol 1985;14(10):751-778.
  25. Comet assay on cervical epithelial cells and leucocytes of patients with precancerous and cancerous lesions of the cervix. Med Sci Res 1994;22(12):879-882.
  26. DNA damage in exfoliated buccal cells of smokers assessed by the single cell gel electrophoresis assay. Mutat Res 1996;370(2):115-120.
  27. Changes in polymorphonuclear leukocytes as a manifestation of malignant neoplasia. Cancer 1968;22(1):35-42.
  28. Atypical monocytes in patients with malignant tumors. Acta Cytol 1966;10(3):197-199.
  29. Symptom control issues and supportive care of patients with head and neck cancers. Clin Adv Hematol Oncol 2007;5(10):807-822.
  30. Delay in diagnosis and its effect on outcome in head and neck cancer. Br J Oral Maxillofac Surg 2005;43(4):281-284.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.